Molecular Detection
Wayne · Founded 2007
About Molecular Detection
Molecular Detection Inc. (MDI) is developing and commercializing a portfolio of "sample-to-answer" Detect-Ready™ molecular diagnostic tests for the rapid detection of infectious diseases. The company is preparing to launch its first product, the Detect-Ready assay for the rapid detection of methicillin-resistant Staphylococcus aureus (MRSA), a growing problem among hospitals and other health facilities around the globe.
Company Facts
- Founded: 2007
- Legal name: Molecular Detection Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.2M
- Last round: Series Unknown (Dec 2013)
- Website: detect-ready.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/molecular-detection-8316483 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.